Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency ...

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

Spotlight PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism ...

Blogs ...

The Benefits Eligibility Solution's contract cost has nearly doubled and it's years overdue, as the state grapples with ...

Why Bitcoin's True Power Lies In Motion . Michael Saylor, you've come to realize that all assets intended for storing ...

Some Gazans are now saying "enough" to a brutal terrorist organization that has comprehensively failed its people.

AstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...